Rationale, study design and implementation of the COLM study: The combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients

Toshio Ogihara, Takao Saruta, Hiromi Rakugi, Kazuaki Shimamoto, Sadayoshi Ito, Hiroaki Matsuoka, Masatsugu Horiuchi, Tsutomu Imaizumi, Shuichi Takishita, Jitsuo Higaki, Shigehiro Katayama, Ikuo Saito, Kazuyuki Shimada

研究成果: Article査読

22 被引用数 (Scopus)

抄録

The COLM study is an investigator-initiated trial comparing the combination therapy using an angiotensin II receptor blocker (ARB), olmesartan, and a calcium channel blocker (CCB) with that using an ARB and a diuretic in high-risk elderly hypertensive patients. Here we describe the rationale and study design. Olmesartan was administered concomitantly with a long-acting dihydropyridine CCB (ARB/CCB group) or with a low-dose diuretic (ARB/diuretic group) to elderly hypertensive patients with a history of or risk factors for cardiovascular disease. Cardiovascular morbidity and mortality as a primary end point were compared between the two groups, with the target blood pressure (BP) being <140mmHg for systolic BP and <90mmHg for diastolic BP. Safety and tolerability will also be investigated. A total of more than 4000 patients were recruited and will be followed up for at least 3 years.

本文言語English
ページ(範囲)163-167
ページ数5
ジャーナルHypertension Research
32
2
DOI
出版ステータスPublished - 2009
外部発表はい

ASJC Scopus subject areas

  • 内科学
  • 生理学
  • 循環器および心血管医学

フィンガープリント

「Rationale, study design and implementation of the COLM study: The combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル